ExploreWatchlistsPricing
  1. JP-listed companies
  2. MEDIPAL HOLDINGS CORPORATION
  3. Financials
  4. Cash from investing

MEDIPAL HOLDINGS CORPORATION (7459)

Market cap
¥578.9B
P/E ratio
14.1x
Medipal Holdings distributes pharmaceuticals, medical devices, cosmetics, daily necessities, and veterinary products through 34 subsidiaries across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 20269,299-376.51%
Mar 31, 2025-3,363-56.98%
Mar 31, 2024-7,817-80.21%
Mar 31, 2023-39,494+62.24%
Mar 31, 2022-24,343+728.27%
Mar 31, 2021-2,939-77.93%
Mar 31, 2020-13,319-43.35%
Mar 31, 2019-23,512-45.40%
Mar 31, 2018-43,064+279.28%
Mar 31, 2017-11,354-72.49%
Mar 31, 2016-41,267+248.72%
Mar 31, 2015-11,834

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat